Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations
Winder GS, Andrews SR, Banerjee AG, Hussain F, Ivkovic A, Kuntz K, Omary L, Shenoy A, Thant T, VandenBerg A, Zimbrean P. Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations. Transplantation Reviews 2022, 36: 100715. PMID: 35853383, DOI: 10.1016/j.trre.2022.100715.Peer-Reviewed Original ResearchConceptsSolid organ transplantationCannabinoid useOrgan transplantationClinical careUS transplantation centersSOT patientsKidney transplantationTransplantation centersCannabinoid effectsClinical impactClinicians' perceptionsMedical literaturePatientsTransplantationCliniciansCannabinoidsCareInterprofessional issuesPsychiatric perspectiveFuture studiesUse ratesProfessional societiesSystematized reviewOngoing dilemmaRecommendationsMood Disorders in Transplantation: Bipolar Disorder Spectrum
Dahal R, Zimbrean P. Mood Disorders in Transplantation: Bipolar Disorder Spectrum. 2022, 13-22. DOI: 10.1007/978-3-031-15052-4_2.ChaptersBipolar disorderEnd-stage organ failureNeuropsychiatric adverse effectsRole of psychotropicsOrgan transplant recipientsSolid organ transplantationStandard immunosuppressantsPharmacological managementTransplant outcomesTransplant recipientsOrgan failureDisease burdenBipolar disorder spectrumSuccessful transplantationOrgan transplantationMood disordersGeneral populationTransplantationPatientsAdverse effectsDisorder spectrumDisordersPsychological effectsNonadherenceImmunosuppressants